Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence
Expert Opinion in Pharmacotherapy, 10/19/09
Mammen K et al. – The addition of naloxone does not appear to affect the efficacy of buprenorphine as a maintenance drug. While offering some deterrence of injection through precipitated withdrawal, there are many circumstances where injecting of buprenorphine–naloxone is reinforcing rather than aversive. The combination will reduce, but not eliminate, intravenous misuse; clinicians therefore need to monitor patients in OST, and be selective in providing patients with medication to be taken without observation.
Related Articles
Systemic opioid and chronic pain
European Journal of Pain, 11/12/09
Relevance Score: 69%
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
Endocrine Reviews, 11/11/09
Relevance Score: 68%
Opioid Use for Chronic Low Back Pain: A Prospective, Population-based Study Among Injured Workers in Washington State, 2002-2005
The Clinical Journal of Pain, 10/20/09
Relevance Score: 68%
Take multiple factors into account when choosing the best opioid for pain therapy in paediatric palliative care
Drugs & Therapy Perspectives, 10/16/09
Relevance Score: 68%
Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia
Clinical Pharmacology & Therapeutics, 11/17/09
Relevance Score: 67%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Modafinil for multiple sclerosis fatigue: Does it work
Clinical Neurology and Neurosurgery, 12/18/09
Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry in six countries
Current Medical Research and Opinion, 12/18/09
Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
Phytotherapy Research, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor